- Home >
- Life Sciences >
- Pharmaceutical >
- Drug and Medication >
US Analgesics 2005
US Analgesics 2005
- Report price : $ 300
- Publication date : June 2005
- Length : 14 pages
US Analgesics 2005
Snapdata's US Antacids 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts. The report gives an instant overview of the US antacid market, and covers antacids and flatulence remedies, including tablets, liquids, and powders. Market size by value is based on sales through mass market channels. The data is supplied in both graphical and tabular format for ease of interpretation and analysis. US Antacids 2005 forms part of Snapdata's OTC Pharmaceuticals industry coverage.
RELATED REPORTS
US Internal Analgesics 2004
- $ 300
- July 2004
- 14 pages
Snapdata's US Internal Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US internal analgesic market, and covers non-prescription tablet and liquid pain killers. Market size is based on retail sales th ...
Industries : Drug and Medication, Over-The-Counter Drug | Countries : USA
US Internal Analgesics 2005
- $ 300
- June 2005
- 13 pages
Snapdata's US Internal Analgesics 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts. The report gives an instant overview of the US internal analgesic market, and covers non-prescription tablet and liquid pain killers. Internal analgesics are also known as ...
Industries : Drug and Medication, Over-The-Counter Drug | Countries : USA
US External Analgesics 2004
- $ 300
- July 2004
- 16 pages
Snapdata's US External Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US external analgesic market, and covers analgesic chest rubs and creams, air-activated heat wraps and patch products. Market siz ...
Industries : Drug and Medication, Over-The-Counter Drug | Countries : USA
Pipeline Insight: Neuropathic Pain - Pipeline Drugs Fail to Nail Neuropathic Pain
- $ 11 400
- July 2005
- 183 pages
Introduction The neuropathic pain market has traditionally been a poorly defined area, with widely varying drug classes prescribed. With many drugs now in clinical trials for key neuropathic pain sub-types, pharma companies with powerful marketing arms are expected to bring attention to this pot ...
Industries : Drug and Medication, Therapy | Countries : USA, Japan
Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US
- $ 1 900
- July 2005
- 175 pages
The new report, Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US, examines the actions taken by legislative and regulatory bodies in response to recent drug safety concerns surrounding the COX-2 inhibitors and antidepressants. The report also ...
Industries : Drug and Medication | Countries : USA, United Kingdom
OTC Analgesics in the United States
- $ 248
- June 2005
- 10 pages
Euromonitor International’s ‘OTC Analgesics in the United States' Major Market Profile report offers an introduction to the market. It is c. 10 pages long and provides a top line overview of sales trends and key player performance. With data coverage from 1999-2004, this report highlights marke ...
Industries : Over-The-Counter Drug, Drug and Medication | Countries : USA
Related industries
reportlinker.com © Copyright 2009. All rights reserved